SEARCH

SEARCH BY CITATION

References

  • 1
    Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800809.
  • 2
    Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. J Hepatol 1997; 26: 312324.
  • 3
    Bosch J, Mastai R, Kravetz D, Bruix J, Gaya J, Rigau J, et al. Effects of propanolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis. HEPATOLOGY 1984; 4: 12001205.
  • 4
    Feu F, Garcia Pagan JC, Bosch J, Luca A, Teres J, Escorsell A, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995; 346: 10561059.
  • 5
    Garcia Pagan JC, Escorsell A, Moitinho E, Bosch J. Influence of pharmacological agents on portal hemodynamics basis for its use in the treatment of portal hypertension. Semin Liver Dis 1999; 19: 427438.
  • 6
    Stiegmann GV, Goff JS, Michaletz-Onody PA, Korula J, Lieberman D, Saeed ZA, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992; 326: 15271532.
  • 7
    Gimson AES, Ramage JK, Panos MZ, Harrison PM, Williams R, Westaby D. Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophagel varices. Lancet 1993; 342: 391394.
  • 8
    Hou MC, Lin HC, Kuo B, Chen CH, Lee FY, Lee SD. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal varices haemorrhage: a prospective randomized trial. HEPATOLOGY 1995; 21: 15171522.
  • 9
    Lo GH, Lai KH, Cheng JS, Hwu JS, Chang CF, Chen SM, et al. A prospective randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. HEPATOLOGY 1995; 22: 466471.
  • 10
    Avgerinos A, Armonis A, Manolakopoulos S, Poulianos G, Rekoumis G, Sgourou A, et al. Endoscopic sclerotherapy versus variceal ligation in the long-term management of patients with cirrhosis alter variceal bleeding: a prospective randomized study. J Hepatol 1997; 26: 10341041.
  • 11
    Baroncini D, Milandri GL, Borioni D, Cennamo V, Billi P, Dal Monte PP, et al. A prospective randomized trial of sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices. Endoscopy 1997; 29: 235240.
  • 12
    Laine L, El-Newihi HM, Migikovsky B, Sloane R, Garcia F. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med 1993; 119: 17.
  • 13
    de la Peña J, Rivero M, Sanchez E, Fabrega E, Crespo J, Pons Romero F. Variceal ligation compared with endoscopic sclerotherapy for variceal haemorrhage: prospective randomized trial. Gastrointest Endosc 1999; 49: 417423.
  • 14
    Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 1995; 123: 280287.
  • 15
    Villanueva C, Miñana J, Ortiz J, Gallego A, Soriano G, Torras X, et al. Endoscopic ligation compared with combined treatment with Nadolol and Isosorbide Mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001; 345: 647655.
  • 16
    Lo GH, Chen WC, Chen MH, Hsu PI, Lin CK, Tsai WL, et al. Banding ligation versus Nadolol and Isosorbide Mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology 2002; 123: 728734.
  • 17
    Patch D, Sabin CA, Goulis J, Gerunda G, Greenslade L, Merkel C, et al. A randomised, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 2002; 123: 10131019.
  • 18
    Lo GH, Lai KH, Cheng JS, Chen MH, Huang HC, Hsu PI, et al. Endoscopic variceal ligation plus Nadolol and Sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective randomized trial. HEPATOLOGY 2000; 32: 461465.
  • 19
    Runyon B. Management of adult patients with ascites due to cirrhosis. HEPATOLOGY 2004: 39: 841856.
  • 20
    Owens WD, Felts JA, Spitznagel EL Jr. ASA physical status classification: a study of consistence of ratings. Anesthesiology 1978; 49: 239243.
  • 21
    Sarin SK, Lahoti D, Saxena SP, Murthi NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. HEPATOLOGY 1992; 16: 13431349.
  • 22
    de Francis R. Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 846852.
  • 23
    D'Amico, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. HEPATOLOGY 1995; 22: 332353.
  • 24
    Garcia Pagan JC, Feu F, Bosch J, Rodes J. Propranolol compared with Propranolol plus Isosorbide-5-Mononitrate for portal hypertension in cirrhosis. A randomized controlled study. Ann Intern Med 1991; 114: 869873.
  • 25
    Sarin SK, Lamba GS, Kumar M, Misra A, Murthy NS. Comparison of endoscopic ligation and Propranolol for the prevention of variceal bleeding. N Engl J Med 1999; 340: 988993.
  • 26
    Burroughs AK, Patch D. Primary prevention of bleeding from esophageal varices. N Engl J Med 1999; 340: 10331031033105.
  • 27
    O'Connor KW, Lehman G, Yune H, Brunelle R, Christiansen P, Hast J, et al. Comparison of three nonsurgical treatments for esophageal varices. Gastroenterology 1989; 96: 899906.
  • 28
    Ink O, Martin T, Poynard T, Reville M, Anciaux ML, Lenoir C, et al. Does elective sclerotherapy improve the efficacy of long-term Propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial. HEPATOLOGY 1992; 16: 912919.
  • 29
    Vinel JP, Lamouliatte H, Cales P, Combis JM, Roux D, Desmorat H, et al. Propranolol reduces the rebleeding rate during injection sclerotherapy before variceal obliteration. Gastroenterology 1992; 102: 17601763.
  • 30
    Jensen LS, Krarup N. Propranolol in prevention of rebleeding from oesophageal varices during the course of endoscopic sclerotherapy. Scand J Gastroenterol 1989; 24: 339345.
  • 31
    Avgerinos A, Rekoumis G, Klonis Ch, Papadimitriou N, Gouma P, Pournanas S, et al. Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial. J Hepatol 1993; 19: 301311.
  • 32
    Vickers C, Rhodes J, Chesner I, Hillenbrand P, Dawson J, Cockel R, et al. Prevention of rebleeding from oesophageal varices: two-year follow-up of a prospective controlled trial of Propranolol in addition to sclerotherapy. J Hepatol 1994; 21: 8187.
  • 33
    Lundell L, Leth R, Lind T, Lonroth H, Sjovall M, Olbe L. Evaluation of Propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions. Acta Chir Scand 1990; 156: 711715.
  • 34
    Westaby D, Melia W, Hegarty J, Gimson AES, Stellon AJ, Williams R. Use of Propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration. HEPATOLOGY 1986; 6: 673675.
  • 35
    O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549556.
  • 36
    D'Amico, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999; 19: 475505.
  • 37
    Lui HF, Stanley AJ, Forrest EH, Jalan R, Stuart Hislop W, Mills PR, et al. Primary prophylaxis of variceal haemorrhage: a randomized controlled trial comparing band ligation, Propranolol, and Isosorbide Mononitrate. Gastroenterology 2002; 123: 735744.
  • 38
    de la Peña J, Rivero M, Garcia-Suarez C, Brullet E, Campo R, Sánchez-Hernández E, et al. Band ligation plus Nadolol compared with variceal ligation after bleeding. Multicenter randomized trial. Preliminary results. Gastrointest Endosc 2003; 124( Suppl 1): A733.